Botulinum Toxin in Oculoplasty: An Overview
Chemodenervation by botulinum neurotoxin (BoNT) has significantly evolved over years since Alan Scott first described its use in 1970s for treatment of strabismus. It has been used for a wide variety of diseases. It has surpassed other treatment options to become the first line of therapy among ocul...
Saved in:
| Main Authors: | Sindhuja Murugesan, Renu Bansal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-09-01
|
| Series: | TNOA Journal of Ophthalmic Science and Research |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/tjosr.tjosr_87_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blepharospasm with elevated anti-acetylcholine receptor antibody titer
by: Min Tang, et al. -
Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?
by: Fátima de Menezes Dantas, et al.
Published: (2025-01-01) -
Toxina botulínica no blefaroespasmo, no espasmo hemifacial e na distonia cervical: resultados em 33 pacientes Botulinum toxin in blepharospasm, hemifacial spasm and cervical dystonia: results in 33 patients
by: Sérgio Ap. Novis, et al.
Published: (1995-09-01) -
Botulinum toxin type A in the treatment of hemifacial spasm: an 11-year experience Toxina botulínica tipo A no tratamento do espasmo hemifacial: 11 anos de experiência
by: Egberto Reis Barbosa, et al.
Published: (2010-08-01) -
Experiência com aplicação de toxina botulínica A em 115 pacientes Botulinum toxin A: experience in the treatment of 115 patients
by: Luiz Augusto F. Andrade, et al.
Published: (1997-09-01)